Bringing unresectable liver disease to resection with curative intent
- 1 December 2007
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 33, S42-S51
- https://doi.org/10.1016/j.ejso.2007.09.017
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapyAnnals of Oncology, 2007
- Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?Journal of Clinical Oncology, 2006
- Combined Liver Resection and Reconstruction of the Supra-Renal Vena CavaAnnals of Surgery, 2006
- Extended right-sided liver resection for colorectal liver metastases—impact of percutaneous portal venous embolisationEuropean Journal of Surgical Oncology, 2006
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal Of Cancer, 2001
- Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] MetastasesAnnals of Surgical Oncology, 2001
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- Resection of Hepatic Metastases from Colorectal Cancer Biologic PerspectivesAnnals of Surgery, 1989